An FDA panel has overwhelmingly voted to recommend approval of the Cartiva Inc.'s Cartiva synthetic cartilage toe implant despite strong reservations that the firm's data is relatively weak.
On April 20, the FDA's Orthopaedic and Rehabilitation Devices Panel voted 8-2 with two abstentions that the benefits of the...